F096 Little Zebras, Ponies, and Pearls: Instructive Pediatric Dermatology Cases
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Case-based scenarios of skin disorders in children and adolescents will be utilized to review the differential diagnosis of skin findings in this population and to discuss approaches for evaluation and management of these disorders. This session will discuss laboratory testing strategies, provide updates from recent medical literature, and offer clinically useful “practice pearls.” Topics explored will range from inflammatory, infectious, neoplastic, and genetic skin diseases to birthmarks and infestations.
LEARNING OBJECTIVES
Discuss the clinical presentation of pediatric dermatologic conditions
Utilize laboratory testing when appropriate to diagnose pediatric dermatologic disorders
Apply knowledge from clinical pearls to the diagnosis and management of pediatric skin disease
SCHEDULE
10:30 PM
Blistering disorders
Raegan D. Hunt, MD, PhD, FAAD
10:50 PM
Cutaneous infections
Lucia Zoraida Diaz, MD, FAAD
11:10 PM
Q&A
Raegan D. Hunt, MD, PhD, FAAD, Lucia Zoraida Diaz, MD, FAAD
11:15 PM
Alopecia
Cathryn Joy Sibbald, MD, FAAD
11:35 PM
Ichthyoses
Grace Liao Lee, MD, FAAD
11:55 PM
Q&A
Grace Liao Lee, MD, FAAD, Cathryn Joy Sibbald, MD, FAAD
12:00 AM
Connective tissue disorders
Diana Reusch, MD, FAAD
12:25 AM
Q&A
Diana Reusch, MD, FAAD
SPEAKERS
Colleen Cotton, MD, FAAD
Lucia Zoraida Diaz, MD, FAAD
Raegan D. Hunt, MD, PhD, FAAD
Grace Liao Lee, MD, FAAD
Diana Reusch, MD, FAAD
Cathryn Joy Sibbald, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Colleen Cotton, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Salary); HS Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Inner Archways LLC – Advisory Board(Other Financial Benefit); Janssen Biotech – Advisory Board(Other Financial Benefit); LEO Pharma, US – Advisory Board(Honoraria); Novartis – Other(Other Financial Benefit); Pierre Fabre – Consultant(Honoraria); Regeneron – Investigator(Salary); TARGET Pharma – Investigator(Salary); UCB – Other(Other Financial Benefit);
Lucia Zoraida Diaz, MD, FAAD
Janssen Pharmaceuticals, Inc – Investigator(No Compensation Received); Regeneron – Investigator(No Compensation Received); UpToDate, Inc – Other(Honoraria);
Raegan D. Hunt, MD, PhD, FAAD
Chiesi – Advisory Board(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); GlycosBio, Inc – Advisory Board(Stock Options), Stockholder Private Company(Stock); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Fees); Palvella Therapeutics – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees); Rhythm Pharmaceuticals – Investigator(Fees); Rhythm Pharmaceuticals, Inc. – Investigator(Fees); Timber Pharmaceuticals – Data Safety Monitoring Board(Fees); UpToDate, Inc – Other(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);
Grace Liao Lee, MD, FAAD
No financial relationships exist with ineligible companies.
Diana Reusch, MD, FAAD
Addlife ab – Stockholder Public Company(Stock); Cigna – Stockholder Public Company(Stock); DaVita Inc. – Stockholder(Stock); Elevance Health – Stockholder Public Company(Stock); Encompass Health – Stockholder Public Company(Stock); Enhabit Home Health & Hospice – Stockholder Public Company(Stock); Google – Stockholder Public Company(Stock); Merck – Stockholder(Other Financial Benefit); ModivCare – Stockholder(Stock); Organon & Co. – Stockholder Public Company(Stock); Psychemedics Corporation – Stockholder Public Company(Stock);
Cathryn Joy Sibbald, MD, FAAD
AbbVie – Speaker(Honoraria); Incyte – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria); Miravo – Advisory Board(Honoraria); Novartis – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Speaker(Honoraria);